Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish
SUMMARY Cardio-facio-cutaneous (CFC) syndrome is caused by germline mutations in KRAS, BRAF and MEK1/2. The highly selective and potent MEK inhibitors that have been developed as anti-cancer agents hold potential as therapeutics for CFC syndrome. We have previously shown that the effects of CFC muta...
Saved in:
Main Authors: | Corina Anastasaki (Author), Katherine A. Rauen (Author), E. Elizabeth Patton (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2012-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mek1Y130C mice recapitulate aspects of human cardio-facio-cutaneous syndrome
by: Rifdat Aoidi, et al.
Published: (2018) -
Cardio-facio-cutaneous Syndrome with Severe Inflammatory Cutaneous Lesions: Dramatic Effect of Dupilumab
by: Sara A. Altandi, et al.
Published: (2024) -
Case report: Gastroenterological management in a case of cardio-facio-cutaneous syndrome
by: B. Ciacchini, et al.
Published: (2023) -
Exploring the clinical complexity of cardio-facio-cutaneous syndrome: insights from a pediatric case series
by: Yuexu Ou, et al.
Published: (2024) -
Cardio-facio-cutaneous syndrome and gastrointestinal defects: report on a newborn with 19p13.3 deletion including the MAP 2 K2 gene
by: Gregorio Serra, et al.
Published: (2022)